By: Hector Chichoni, Esq. and Nick Richards, Esq.
The intersection of U.S. immigration law and the cannabis industry remains a complex legal minefield. Despite recent important changes and widespread state-level legalization, most cannabis-related activities for purposes of U.S. immigration are seen through a lens of federal prohibition, which could of Cannabis lead to severe consequences for foreign nationals, business owners, and investors.
In a historic pivot on April 23, 2026, the U.S. Department of Justice (DOJ) officially reclassified certain cannabis products from Schedule I to Schedule III of the Controlled Substances Act (CSA). While this change eases research barriers and tax burdens for the medical industry, its impact on non-citizens remains limited. For immigration purposes, cannabis continues to be a federally controlled substance, meaning legal risks for immigrants are largely unchanged. Moreover, even though medical cannabis was moved to Schedule III, the medical cannabis industry is largely not an approved Schedule III provider, absent registration with the DEA.
The Scope of Reclassification
The April 2026 final order specifically moves two categories of marijuana to Schedule III:
- FDA-approved drug products containing marijuana.
- Marijuana is subject to a state-issued license for medical purposes only.
Recreational cannabis remains in Schedule I, meaning its possession and distribution remain fully illegal under federal law. A broad hearing to evaluate rescheduling all marijuana is set to begin on June 29, 2026.
Why Immigration Consequences Persist
For immigrants, the critical distinction is that “rescheduling” is not the same as “descheduling” or legalization.
Under the Immigration and Nationality Act (INA), any violation of a law relating to a “controlled substance” as defined in the CSA, which includes all drugs in Schedules I through V, can trigger immigration penalties. Since cannabis remains on the federal schedules, even at Schedule III, it still falls under these strict rules.
Non-citizens can still face detention, deportation, or be found inadmissible for cannabis-related conduct, even if it is legal under state law. This includes personal use or working in the state-licensed industry.
To naturalize as a U.S. citizen, applicants must demonstrate “good moral character.” Federal guidelines from USCIS state that involvement with cannabis, even in states where it is legal, can prevent an applicant from meeting this requirement.
Summary of Risks for Non-Citizens
We advise non-citizens to remain extremely cautious:
- Working in a dispensary or at a grow facility may be interpreted as “drug trafficking” for immigration purposes, regardless of state licenses.
- Even with a doctor’s recommendation in a legal state, using medical cannabis remains a federal violation that can jeopardize a green card or visa.
- Customs and Border Protection (CBP) can still deny entry or revoke status for admissions of cannabis use at the border.
While the move to Schedule III is a significant step toward federal medical recognition, it does not provide a “safe harbor” for immigrants. Until cannabis is fully removed from the Controlled Substances Act, non-citizens should consult with an attorney before engaging in any activity involving the drug.
